Guided Therapeutics (GTHP) Change in Cash (2011 - 2025)
Guided Therapeutics' (GTHP) quarterly Change in Cash came in at -$24000.0 in Q4 2025, down 112.37% year-on-year from $194000.0 in Q4 2024, and up 75.51% quarter-over-quarter from -$98000.0 in Q3 2025.
Guided Therapeutics (GTHP) Change in Cash (2011 - 2025) Analysis & Trends
Guided Therapeutics has disclosed Change in Cash across 15 years of filings, most recently posting -$24000.0 for Q4 2025.
- Change in Cash for Q4 2025 came in at -$24000.0, down 112.37% year-over-year; the trailing twelve-month figure through Dec 2025 was -$325000.0 (down 60.1% YoY), and the FY2025 annual result was -$325000.0, down 60.1% from the prior year.
- Change in Cash came in at -$24000.0 for Q4 2025 at Guided Therapeutics, up from -$98000.0 in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $2.3 million in Q3 2022 to a low of -$627000.0 in Q3 2023.
- The 5-year median for Change in Cash is -$143000.0 (2023), against an average of -$5950.0.
- Across the five-year window, Change in Cash surged 690.81% in 2022 and plunged 680.49% in 2023, its largest moves.
- Guided Therapeutics' Change in Cash stood at $102000.0 in 2021, then slumped by 476.47% to -$384000.0 in 2022, then surged by 63.54% to -$140000.0 in 2023, then surged by 238.57% to $194000.0 in 2024, then tumbled by 112.37% to -$24000.0 in 2025.
- The last three Change in Cash figures came in at -$24000.0 (Q4 2025), -$98000.0 (Q3 2025), and $70000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -1.72 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.13 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -136.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -504.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -492.00 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -2.23 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 15.90 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | -24,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -24,000.00 |
| Sep 30, 2025 | -98,000.00 |
| Jun 30, 2025 | 70,000.00 |
| Mar 31, 2025 | -273,000.00 |
| Dec 31, 2024 | 194,000.00 |
| Sep 30, 2024 | -81,000.00 |
| Jun 30, 2024 | -170,000.00 |
| Mar 31, 2024 | -146,000.00 |
| Dec 31, 2023 | -140,000.00 |
| Sep 30, 2023 | -627,000.00 |
| Jun 30, 2023 | -479,000.00 |
| Mar 31, 2023 | -476,000.00 |
| Dec 31, 2022 | -384,000.00 |
| Sep 30, 2022 | 2.25 Mn |
| Jun 30, 2022 | -279,000.00 |
| Mar 31, 2022 | 82,000.00 |
| Dec 31, 2021 | 102,000.00 |
| Sep 30, 2021 | -381,000.00 |
| Jun 30, 2021 | -325,000.00 |
| Mar 31, 2021 | 1.07 Mn |